109 related articles for article (PubMed ID: 17296590)
1. Influence of genetic polymorphisms in CYP3A4, CYP3A5, GSTP1, GSTM1, GSTT1 and MDR1 genes on survival and therapy-related toxicity in multiple myeloma.
Schilthuizen C; Broyl A; van der Holt B; de Knegt Y; Lokhorst H; Sonneveld P
Haematologica; 2007 Feb; 92(2):277-8. PubMed ID: 17296590
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and toxicity of docetaxel: role of CYP3A, MDR1, and GST polymorphisms.
Tran A; Jullien V; Alexandre J; Rey E; Rabillon F; Girre V; Dieras V; Pons G; Goldwasser F; Tréluyer JM
Clin Pharmacol Ther; 2006 Jun; 79(6):570-80. PubMed ID: 16765145
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms of CYP3A4, GSTT1, GSTM1, GSTP1 and NQO1 and the risk of acquired idiopathic aplastic anemia in Caucasian patients.
Dufour C; Svahn J; Bacigalupo A; Longoni D; Varotto S; Iori AP; Bagnasco F; Locasciulli A; Menna G; Ramenghi U; Lanciotti M; ;
Haematologica; 2005 Aug; 90(8):1027-31. PubMed ID: 16079101
[TBL] [Abstract][Full Text] [Related]
4. Polymorphic variations in GSTM1, GSTT1, PgP, CYP2D6, CYP3A5, and dopamine D2 and D3 receptors and their association with tardive dyskinesia in severe mental illness.
de Leon J; Susce MT; Pan RM; Koch WH; Wedlund PJ
J Clin Psychopharmacol; 2005 Oct; 25(5):448-56. PubMed ID: 16160620
[TBL] [Abstract][Full Text] [Related]
5. Drug-metabolizing enzyme polymorphisms predict clinical outcome in a node-positive breast cancer cohort.
DeMichele A; Aplenc R; Botbyl J; Colligan T; Wray L; Klein-Cabral M; Foulkes A; Gimotty P; Glick J; Weber B; Stadtmauer E; Rebbeck TR
J Clin Oncol; 2005 Aug; 23(24):5552-9. PubMed ID: 16110016
[TBL] [Abstract][Full Text] [Related]
6. Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.
Ekhart C; Doodeman VD; Rodenhuis S; Smits PH; Beijnen JH; Huitema AD
Pharmacogenet Genomics; 2008 Jun; 18(6):515-23. PubMed ID: 18496131
[TBL] [Abstract][Full Text] [Related]
7. CYP3A5 and CYP3A4 but not MDR1 single-nucleotide polymorphisms determine long-term tacrolimus disposition and drug-related nephrotoxicity in renal recipients.
Kuypers DR; de Jonge H; Naesens M; Lerut E; Verbeke K; Vanrenterghem Y
Clin Pharmacol Ther; 2007 Dec; 82(6):711-25. PubMed ID: 17495880
[TBL] [Abstract][Full Text] [Related]
8. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
[TBL] [Abstract][Full Text] [Related]
9. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
[TBL] [Abstract][Full Text] [Related]
10. GSTT1, GSTM1, and GSTP1 polymorphisms and chemotherapy response in locally advanced breast cancer.
Oliveira AL; Rodrigues FF; Santos RE; Aoki T; Rocha MN; Longui CA; Melo MB
Genet Mol Res; 2010 Jun; 9(2):1045-53. PubMed ID: 20568049
[TBL] [Abstract][Full Text] [Related]
11. GSTP1, GSTM1, and GSTT1 polymorphisms as predictors of response to chemotherapy in patients with breast cancer: a meta-analysis.
Kong X; Li Z; Li X
Cancer Chemother Pharmacol; 2016 Dec; 78(6):1163-1173. PubMed ID: 27785604
[TBL] [Abstract][Full Text] [Related]
12. GSTM1 and GSTP1, but not GSTT1 genetic polymorphisms are associated with chronic myeloid leukemia risk and treatment response.
Weich N; Ferri C; Moiraghi B; Bengió R; Giere I; Pavlovsky C; Larripa IB; Fundia AF
Cancer Epidemiol; 2016 Oct; 44():16-21. PubMed ID: 27454607
[TBL] [Abstract][Full Text] [Related]
13. Glutathione S-transferase gene polymorphisms (GSTM1, GSTT1, GSTP1) and prostate cancer: a case-control study in Tehran, Iran.
Safarinejad MR; Shafiei N; Safarinejad SH
Prostate Cancer Prostatic Dis; 2011 Jun; 14(2):105-13. PubMed ID: 21243008
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetic screening for polymorphisms in drug-metabolizing enzymes and drug transporters in a Dutch population.
Bosch TM; Doodeman VD; Smits PH; Meijerman I; Schellens JH; Beijnen JH
Mol Diagn Ther; 2006; 10(3):175-85. PubMed ID: 16771603
[TBL] [Abstract][Full Text] [Related]
15. Variation in oral clearance of saquinavir is predicted by CYP3A5*1 genotype but not by enterocyte content of cytochrome P450 3A5.
Mouly SJ; Matheny C; Paine MF; Smith G; Lamba J; Lamba V; Pusek SN; Schuetz EG; Stewart PW; Watkins PB
Clin Pharmacol Ther; 2005 Dec; 78(6):605-18. PubMed ID: 16338276
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms in GST genes and survival of colorectal cancer patients treated with chemotherapy.
Funke S; Timofeeva M; Risch A; Hoffmeister M; Stegmaier C; Seiler CM; Brenner H; Chang-Claude J
Pharmacogenomics; 2010 Jan; 11(1):33-41. PubMed ID: 20017670
[TBL] [Abstract][Full Text] [Related]
17. Impact of genetic polymorphisms on tacrolimus pharmacokinetics and the clinical outcome of renal transplantation.
Gervasini G; Garcia M; Macias RM; Cubero JJ; Caravaca F; Benitez J
Transpl Int; 2012 Apr; 25(4):471-80. PubMed ID: 22369694
[TBL] [Abstract][Full Text] [Related]
18. Association between GSTM1, GSTT1, and GSTP1 polymorphisms and gastric cancer risk, and their interactions with environmental factors.
Chen ZH; Xian JF; Luo LP
Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28198496
[TBL] [Abstract][Full Text] [Related]
19. [Association between GSTP1, GSTM1, GSTT1 genetic polymorphisms and urinary styrene phenyl hydroxyethyl mercapturic acids level].
Han WN; Shao H; Chen XL; Han GZ; Meng X
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2013 Nov; 31(11):830-3. PubMed ID: 24370292
[TBL] [Abstract][Full Text] [Related]
20. GSTT1, GSTM1, and GSTP1 polymorphisms as a prognostic factor in women with breast cancer.
Oliveira AL; Oliveira Rodrigues FF; Dos Santos RE; Rozenowicz RL; Barbosa de Melo M
Genet Mol Res; 2014 Jan; 13(2):2521-30. PubMed ID: 24535908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
